NCT01453686View on ClinicalTrials.gov

A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Alopecia Areata
Interventions
DRUG

Hydrocortisone 1%

Topical cream, used twice daily for 6 weeks on affected area, followed by 6 weeks of no treatment, followed by an additional 6 weeks of the same intervention.

DRUG

Clobetasol Propionate 0.05%

Topical cream, used twice daily for 6 weeks on affected area, followed by 6 weeks of no treatment, followed by an additional 6 weeks of the same intervention.

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT01453686 - A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata | Biotech Hunter | Biotech Hunter